Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a ...

Stem cell therapies are gradually becoming a viable medical option for a range of health conditions. Today, a micro-cap ...

The Dow has always been flawed, but it held on to its status as the iconic gauge of American stocks because a mix of luck and design meant it mostly matched the broader market. No longer. Far from ...

The Dow plunged Wednesday on a disappointing outlook from the Federal Reserve. In the process, the blue-chip index extended its losing streak to 10 days — the longest such stretch since Gerald ...

Johnson & Johnson said the first clinical data from its ongoing Phase 1b study of JNJ-4496, a chimeric antigen receptor T-cell therapy, shows encouraging potential in treating large B-cell ...

Dow is one of the world's largest producers of PE and specialty resins. The firm posted sales of just under $43 billion in full-year 2024 and employs approximately 36,000 globally.